HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Guo-Yuan Yang Selected Research

Edema (Dropsy)

8/2023M2 Microglial Extracellular Vesicles Attenuated Blood-brain Barrier Disruption via MiR-23a-5p in Cerebral Ischemic Mice.
9/2022Transcranial focused ultrasound stimulation reduces vasogenic edema after middle cerebral artery occlusion in mice.
1/2020Oligodendrocyte precursor cells transplantation protects blood-brain barrier in a mouse model of brain ischemia via Wnt/β-catenin signaling.
1/2020P2Y6 receptor inhibition aggravates ischemic brain injury by reducing microglial phagocytosis.
1/2020MicroRNA-126-3p/-5p Overexpression Attenuates Blood-Brain Barrier Disruption in a Mouse Model of Middle Cerebral Artery Occlusion.
12/2015MicroRNA-29b is a therapeutic target in cerebral ischemia associated with aquaporin 4.
7/2013The protective role of Tongxinluo on blood-brain barrier after ischemia-reperfusion brain injury.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Guo-Yuan Yang Research Topics

Disease

60Ischemic Stroke
01/2024 - 04/2008
46Brain Ischemia (Cerebral Ischemia)
01/2023 - 09/2003
42Stroke (Strokes)
01/2024 - 04/2008
36Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
10/2023 - 05/2002
35Ischemia
01/2023 - 05/2002
28Infarction (Infarctions)
01/2024 - 09/2003
28Brain Injuries (Brain Injury)
01/2024 - 09/2003
14Brain Infarction
08/2023 - 03/2012
14Arteriovenous Malformations (Arteriovenous Malformation)
09/2017 - 04/2003
10Atrophy
01/2024 - 04/2010
9Inflammation (Inflammations)
02/2024 - 04/2004
9Hypoxia (Hypoxemia)
11/2017 - 04/2004
8Brain Edema (Cerebral Edema)
01/2020 - 12/2011
7Hemorrhage
01/2024 - 05/2005
7Edema (Dropsy)
08/2023 - 07/2013
7Cerebral Hemorrhage
01/2020 - 09/2007
7Aneurysm (Aneurysms)
01/2018 - 06/2008
5Traumatic Brain Injuries (Traumatic Brain Injury)
11/2023 - 12/2011
5Brain Diseases (Brain Disorder)
09/2022 - 01/2006
5Vascular Diseases (Vascular Disease)
11/2017 - 08/2004
5Neoplasms (Cancer)
01/2017 - 01/2003
4Thrombosis (Thrombus)
09/2016 - 06/2008
3Hemorrhagic Stroke
02/2024 - 01/2011
3Neuroinflammatory Diseases
06/2022 - 09/2018
3Hypertension (High Blood Pressure)
12/2018 - 09/2006
3Cerebral Infarction
01/2018 - 04/2008
3Intracranial Aneurysm (Cerebral Aneurysm)
01/2018 - 06/2008
3Hereditary Hemorrhagic Telangiectasia
09/2010 - 02/2004
3Vascular Remodeling
07/2009 - 03/2007
3Rupture
03/2009 - 09/2007
2Neurodegenerative Diseases (Neurodegenerative Disease)
01/2022 - 03/2009
2Colorectal Neoplasms (Colorectal Cancer)
12/2021 - 12/2013
2Pathologic Constriction (Stenosis)
02/2020 - 06/2008
2Reperfusion Injury
10/2019 - 01/2018
2Gliosis
10/2018 - 01/2017
2Cerebrovascular Disorders (Cerebrovascular Occlusion)
05/2018 - 01/2016
2Cognitive Dysfunction
01/2018 - 03/2010

Drug/Important Bio-Agent (IBA)

22Proteins (Proteins, Gene)FDA Link
11/2023 - 05/2002
15MicroRNAs (MicroRNA)IBA
06/2022 - 01/2011
13Interleukin-6 (Interleukin 6)IBA
01/2020 - 01/2006
12Biomarkers (Surrogate Marker)IBA
01/2019 - 03/2009
10Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2024 - 02/2004
10CytokinesIBA
01/2020 - 01/2004
8Immunoglobulin G (IgG)IBA
08/2023 - 01/2013
7erucylphosphocholineIBA
01/2023 - 04/2010
6Matrix Metalloproteinase 9 (Gelatinase B)IBA
09/2022 - 09/2006
6Netrin-1IBA
12/2021 - 03/2011
6Matrix Metalloproteinases (MMPs)IBA
12/2011 - 04/2003
5Evans Blue (Blue, Evans)FDA Link
11/2023 - 12/2011
5OccludinIBA
11/2023 - 01/2013
5Therapeutic UsesIBA
01/2023 - 01/2018
5Neuroprotective AgentsIBA
09/2022 - 11/2017
5Messenger RNA (mRNA)IBA
07/2019 - 01/2004
5Caspase 3 (Caspase-3)IBA
05/2009 - 05/2002
4Glucose (Dextrose)FDA LinkGeneric
11/2023 - 01/2006
4Oxygen (Dioxygen)IBA
11/2023 - 01/2006
4Interleukin-10 (Interleukin 10)IBA
10/2023 - 01/2015
4Tight Junction ProteinsIBA
01/2020 - 11/2017
4methylarginyl- lysyl- prolyl- tryptophyl- tert- leucyl- leucyl- ethyl esterIBA
01/2016 - 03/2011
3VimentinIBA
02/2024 - 10/2018
3Chemokine CXCL12IBA
01/2024 - 08/2009
3Peptides (Polypeptides)IBA
11/2023 - 05/2022
3Peroxidase (Myeloperoxidase)IBA
01/2020 - 06/2008
3Sirolimus (Rapamycin)FDA Link
01/2019 - 02/2014
3Aquaporin 4IBA
12/2018 - 12/2015
3Insulin-Like Growth Factor I (IGF-1)IBA
01/2018 - 04/2008
3Bromodeoxyuridine (BrdU)IBA
01/2017 - 10/2015
3Interleukin-8 (Interleukin 8)IBA
10/2014 - 01/2013
3EndoglinIBA
09/2010 - 02/2004
3Activin Receptors (Activin Receptor)IBA
03/2009 - 02/2004
2Complement C3 (C3 Complement)IBA
02/2024 - 12/2020
2HMGB1 Protein (HMG1)IBA
01/2024 - 10/2014
2cresyl violetIBA
01/2024 - 10/2006
2N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
11/2023 - 03/2009
2Metalloproteases (Metalloproteinases)IBA
10/2023 - 04/2003
2Claudin-5IBA
08/2023 - 12/2021
2HydrogelsIBA
01/2023 - 11/2022
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
09/2022 - 03/2009
2ErythropoietinFDA Link
01/2022 - 01/2016
2Myelin Basic ProteinIBA
01/2022 - 10/2015
2CateninsIBA
01/2022 - 01/2020
2Phosphotransferases (Kinase)IBA
12/2021 - 09/2010
2Mitogen-Activated Protein Kinase 3IBA
01/2021 - 05/2002
2p38 Mitogen-Activated Protein KinasesIBA
09/2020 - 12/2016
2CalciumIBA
05/2020 - 04/2007
2EnzymesIBA
01/2020 - 09/2003
2Streptozocin (Streptozotocin)FDA Link
01/2020 - 04/2016
2Tissue Plasminogen Activator (Alteplase)FDA Link
12/2019 - 01/2016
23-n-butylphthalide (butylphthalide)IBA
10/2019 - 01/2019
2Hemoglobins (Hemoglobin)IBA
12/2017 - 11/2017
2AdiponectinIBA
11/2017 - 12/2013

Therapy/Procedure

47Therapeutics
01/2024 - 11/2004
24Transplantation
01/2024 - 08/2005
9Synchrotrons
12/2019 - 01/2012
7Sutures (Suture)
09/2017 - 05/2009
5Lasers (Laser)
01/2019 - 01/2011
3Suture Techniques
04/2014 - 03/2012
2Aftercare (After-Treatment)
01/2024 - 11/2017
2Neurological Rehabilitation
10/2023 - 02/2021
2Intravenous Injections
01/2022 - 01/2021